Colorectal Procedure Market Report | Size & Forecast 2028

Colorectal Procedure Market Forecast to 2028 - Global Analysis by Product (Endoscope, Electrosurgery, Handheld Device & Visual Systems, Sealing & Stapling Devices, Ligation Clips & Dilators & Speculas, Cutter & Shears, Accessories, and Others), Surgery Type [Right Hemicolectomy, Left Hemicolectomy, Subtotal Hemicolectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others (Including Endoscopic Surgery)], Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Others), End User (Hospital & Clinics, Surgery Centers, and Others)

Publication Month : Jun 2023

  • Report Code : TIPRE00029538
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 251
Inquire Before Buy



[Research Report] The colorectal procedure market is projected to reach US$ 27,627.76 million by 2028 from US$ 13,690.71 million in 2022. It is expected to register a CAGR of 12.6% from 2023 to 2028.

Analyst Perspective

The rising prevalence of colorectal cancer and new product launches drive the colorectal procedure market growth. With the growing pervasiveness of cancer, the increasing awareness of the disease and the associated treatment is also rising. Additionally, government initiatives provide better and more affordable treatments and favorable reimbursement policies, which are expected to boost the colorectal procedure market growth. Furthermore, the colorectal procedure market key players are focusing on strategic initiatives by launching new products to expand their geographic reach and enhance capacities to cater to a large customer base. For instance, in August 2021, Ethicon announced the ECHELON CIRCULAR Powered Stapler results. The product helped in a 74% reduction in the anastomotic leak and a 44% reduction in 30-day inpatient hospital readmission rates after colorectal surgery compared to the manual circular staplers.

Market Overview

A colorectal procedure is an operation with colon resection, and anastomosis is performed to treat various pathologies such as ulcerative colitis, Crohn's disease, mechanical obstruction, recurrent obstruction, recurrent diverticulitis, etc. The procedure helps remove all or part of the colon. Neighboring lymph nodes are also removed. When only part of the colon is removed, it is called a hemicolectomy, partial colectomy, or segmental resection. The surgeon removes the part of the colon with cancer and a small segment of the normal colon on either side. Colorectal surgery is associated with a higher morbidity and mortality risk than other general surgical subspecialties. According to the National Library of Medicine, all-cause mortality rates after colorectal surgery range from 1% to 16.4%, with morbidity rates as high as 35%. However, advances in surgical techniques in bowel surgery and a different therapeutic approach by medical staff have led to the emergence of techniques aimed at reducing the length of hospital stay of the patients. These techniques are also known as early or multimodal rehabilitation, which proposes a different global strategy to reduce morbidity and mortality, reduce hospital stays, and improve the quality of life of these patients.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Colorectal Procedure Market: Strategic Insights

Market Size Value inUS$ 13,690.71 million in 2022
Market Size Value byUS$ 27,627.76 million by 2028
Growth rateCAGR of 12.6% from 2023 to 2028
Forecast Period2023-2028
Base Year2022
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Driver

Increasing Prevalence of Colorectal Cancer Drives Global Colorectal Procedure Market

Colorectal cancer is one of the most commonly found and lethal cancers developed in individuals with the combined influence of genetic and environmental factors. According to the World Health Organization (WHO), colorectal cancer is the third most prevalent form of cancer, with ~1.93 million global cases in 2020. Furthermore, colorectal cancer mortality and incidence rates vary globally, and ~916,000 deaths in 2020 were due to colorectal cancer. It is the third most common cancer in men and the second most common cancer in women. The lifetime risk of developing colorectal cancer is about 1 in 23 for men and 1 in 25 for women. About 95,55,027 cancer deaths were recorded in 2018, of which 8,80,792 were related to colorectal cancer. Therefore, colorectal cancer was identified as the third most common cancer and the second most death-causing cancer.

A significant population in North America is diagnosed with colorectal cancer. For instance, according to the Centers for Disease Control and Prevention (CDC) and American Cancer Society, an estimated 1.93 million cases of adults in the US were diagnosed with colon and rectum cancer, and 53,200 deaths were reported with colorectal cancer in 2020. The presence of cancer is similar in European countries. For instance, as per Cancer Research UK, deaths from bowel/colorectal cancer in the UK between 2016 and 2018 were reported to be 16,571. Further, the data suggests ~42,880 new bowel cancer cases in the UK annually, which are over ~110 patients daily.

Colorectal cancer is increasingly affecting the populations in Asian countries. For instance, according to the International Agency for Research on Cancer & GLOBOCAN, the estimated incidence of colorectal cancer in Asia reported ~1,009,400 new cases in 2020. Japan, China, Malaysia, Singapore, Korea, and Turkey are witnessing high prevalence rates compared to the other countries in Asia Pacific.

These statistics showcase increased demand for advanced cancer diagnostics and therapeutics in various regions. Thus, the rising number of patients suffering from the disease is driving the growth of the global colorectal procedure market.

Segmental Analysis

Based on product, the colorectal procedure market is segmented into endoscope, electrosurgery, handheld devices & visual systems, sealing & stapling devices, ligation clips and dilators and speculas, cutter & shears, accessories, and others. The endoscope segment accounted for the largest market share in 2021 and is expected to grow at a CAGR of 13.3% during the forecast period. The market position of this segment is due to the rising cases of colorectal cancer globally. Endoscopes are widely utilized for colorectal treatment. For instance, the Public Library of Science (PLOS) report states that CRC is commonly diagnosed among the 40.7 per 100,000 population and is the third leading cause of cancer death (14.8 per 100,000) in the US as per estimates in 2020. Therefore, demand for endoscopes accelerated to address this issue. Diagnosing colorectal diseases has been increasingly successful owing to advancements in endoscopic technology.  

Regional Analysis

North America is the dominating region in the colorectal procedure market. The North America colorectal procedure market was valued at US$ 6,121.12 million in 2022 and is projected to reach US$ 12,103.72 million by 2028; it is expected to grow at a CAGR of 12.2% during the forecast period. The North America colorectal procedure market is segmented into the US, Canada, and Mexico. The growth can be attributed to age-related problems, increasing government funds, and continuous regional technology improvements. The growth of the colorectal procedure market in the region is expected to grow due to significantly rising incidences of colorectal cancer across the country and growing government support for the research in colon cancer. Moreover, the government provides multiple programs for the betterment of the population. Colorectal cancer is among the five most common cancers diagnosed in the US. The American Cancer Society estimates that there will be approximately 106,000 new cases of colorectal cancer and nearly 45,000 new cases of rectal cancer nationwide in 2022. Although older adults are more likely to develop colorectal cancer, patients are increasing in younger adults. Colectomy, also known as a colectomy or colon resection, is the surgical removal of the diseased part of the intestine or colon. This procedure is recommended for bowel obstruction due to scar tissue or deformity, bleeding, infection, or ulceration due to ulcerative colitis, cancer, precancerous polyps, familial polyposis, or traumatic injury. More than 600,000 surgeries are performed annually in the US to treat colon diseases. According to the American Cancer Society, the 5-year survival rate for localized colon cancer is 91% and for localized rectal cancer is 90%. Overall, colorectal cancer mortality rates have tended to decline with better screening and treatment over the past 20 years. According to the Centers for Disease Control and Prevention, adults ages 45 to 54 experienced a small but significant increase in colorectal cancer death rates. In 2021, the recommended minimum age for routine colorectal cancer screening was lowered from 50 to 45 years.

Key Player Analysis

The colorectal procedure market analysis consists of the players such as Ethicon (Johnson & Johnson Services, Inc.); Medtronic; Colospan Ltd; SAFEHEAL; B. Braun Melsungen AG; Cardinal Health Inc; Boston Scientific Corporation; CooperSurgical, Inc.; Olympus Corporation; and Suturion AB. Among the players in the colorectal procedure market Medtronic and Ethicon are the top two players owing to the diversified product portfolio offered.

Recent Developments

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the colorectal procedure market. A few recent key market developments are listed below:

  • In August 2021, Ethicon announced the results of a new real-world study that shows its Echelon Circular Powered Stapler was associated with a 74% reduction in anastomotic leak rates and a 44% reduction in 30-day inpatient hospital readmission rates after colorectal surgery with manual circular staplers.
  • In March 2022, Medtronic announced final findings from a randomized, international, multi-center center that confirmed the effectiveness of the GI Genius intelligent endoscopy module, which uses AI to detect colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer.
  • In July 2022, B.Braun Medical Inc launched its new Introcan Safety IV Catheter with one-time blood control, ensuring a truly automatic passive safety device protects clinicians. Introcan Safety 2 helps reduce clinician and patient exposure to blood with its one-time Blood Control Septum, which is designed to restrict blood flow from the catheter hub after needle removal until the first connection of a Luer access device. The newly launched Introcan Safety 2 will allow clinicians to experience passive needlestick prevention and a reduced risk of exposure to bloodborne pathogens when removing the introducer needle from Introcan Safety 2. This is all achieved with a product similarly sized to the widely popular Introcan Safety Catheter.
  • In May 2022, Medtronic announced final findings from a randomized, international, multi-center center that confirmed the effectiveness of the GI Genius intelligent endoscopy module, which uses AI to aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer.
  • In February 2022, Safeheal closed a US$ 42.88 Million financing round led by Sifinnova Partners, a European venture capital firm, and Singapore-based medical device company Genesis Medtech. The Colovac device aims to ease digestive surgeries. The funding will help the company continue and accelerate a clinical trial named SAFE-2 in the US and Europe, which the FDA has already approved. The study aims to evaluate the safety and efficacy of the novel surgery approach.
  • In November 2021, Medtronic announced that the US Food and Drug Administration (FDA) granted 510(k) clearance for its PillCam Small Bowel 3 System for remote endoscopy procedures. PillCam SB3 @HOME provides a telehealth option for direct visualization and monitoring of the small bowel.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Surgery Type, Indication, End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What are the driving factors for the colorectal procedure market across the globe?

Increasing prevalence of colorectal cancer and new product launches are some factors responsible for the overall market growth.

Which product led the colorectal procedure market?

Based on product, endoscope took the forefront leaders in the worldwide market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.

What is meant by the colorectal procedure market?

Colorectal surgery involves colonic resection and anastomosis that is performed for the treatment of various pathologies involving ulcerative colitis, Crohn's disease, mechanical obstruction, and recurrent diverticulitis. The specialty of colorectal surgery is unique in several aspects, covering a large part of visceral anatomy.

Which surgery type segment held the largest revenue (US$ Mn) in the colorectal procedure market?

The subtotal colectomy segment dominated the global colorectal procedure market.

What is the regional market scenario of the colorectal procedure market?

Global colorectal procedure market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for colorectal procedure market. The US is expected to hold the largest share in the colorectal procedure market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia Pacific regional growth in the coming years.

Who are the key players in the colorectal procedure market?

Medtronic; Ethicon; Conmed Olumpus Corporation; Suturion; Boston Scientific Corporation; CooperSurgical, Inc; Cadinal Health; Safeheal; B.braun Melsungen AG; and Colospan Ltd; are among the leading companies operating in the global colorectal procedure market

The List of Companies - Colorectal Procedure Market

  1. Ethicon (Johnson & Johnson Services, Inc.)
  2. Medtronic
  3. Colospan Ltd
  5. B. Braun Melsungen AG
  6. Cardinal Health Inc.
  7. Boston Scientific Corporation
  8. CooperSurgical, Inc.
  9. Olympus Corporation
  10. Suturion AB

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports